Enveric Biosciences Inc [NASDAQ: ENVB] stock went on a downward path that fall over -13.87% on Tuesday, amounting to a one-week price decrease of less than -25.32%.
Over the last 12 months, ENVB stock dropped by -90.75%. The one-year Enveric Biosciences Inc stock forecast points to a potential upside of 98.88. The average equity rating for ENVB stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $2.27 million, with 1.92 million shares outstanding and 1.81 million shares in the current float. Compared to the average trading volume of 216.12K shares, ENVB stock reached a trading volume of 4884017 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Enveric Biosciences Inc [ENVB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ENVB shares is $105.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ENVB stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Enveric Biosciences Inc is set at 0.34 The Price to Book ratio for the last quarter was 0.18, with the Price to Cash per share for the same quarter was set at 1.62.
ENVB Stock Performance Analysis:
Enveric Biosciences Inc [ENVB] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -25.32. With this latest performance, ENVB shares dropped by -74.91% in over the last four-week period, additionally sinking by -85.19% over the last 6 months – not to mention a drop of -90.75% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ENVB stock in for the last two-week period is set at 17.77, with the RSI for the last a single of trading hit 11.34, and the three-weeks RSI is set at 22.97 for Enveric Biosciences Inc [ENVB]. The present Moving Average for the last 50 days of trading for this stock 4.0005, while it was recorded at 1.3580 for the last single week of trading, and 7.0999 for the last 200 days.
Insight into Enveric Biosciences Inc Fundamentals:
Enveric Biosciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.56 and a Current Ratio set at 4.56.
Enveric Biosciences Inc [ENVB] Institutonal Ownership Details
The top three institutional holders of ENVB stocks are: ADVISORSHARES INVESTMENTS LLC with ownership of 0.32 million shares, which is approximately 7.9233%. GEODE CAPITAL MANAGEMENT, LLC, holding 44659.0 shares of the stock with an approximate value of $$27688.0 in ENVB stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$27268.0 in ENVB stock with ownership which is approximately 1.0886%.
